Patents by Inventor Amparo Emilia Macias Abraham

Amparo Emilia Macias Abraham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF EPIDERMAL GROWTH FACTOR DEPLETING AGENTS IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Publication number: 20230256069
    Abstract: The present invention is related to the fields of Biotechnology and Medicine. Particularly, it describes the use of epidermal growth factor (EGF) deprivation agents that contribute to lowering and/or depleting serum epidermal growth factor levels, which has implications in the treatment of the chronic obstructive pulmonary disease. These agents can be vaccine compositions comprising as active principle the conjugate between recombinant human EGF and a carrier protein.
    Type: Application
    Filed: July 19, 2021
    Publication date: August 17, 2023
    Inventors: Amparo Emilia Macias Abraham, Tania Crombet Ramos, Kalet León Monzón, Danay Saavedra Hernández, Orestes Santos Morales, Elia Neninger Vinageras, Pedro Pablo Pino Alfonso, Jenysbel de la Caridad Hernandez Reyes, Mary Reid, Kelvin Lee
  • Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)
    Patent number: 9790279
    Abstract: The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N-glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: October 17, 2017
    Assignee: CENTRO DE IMMUNOLOGIA MOLECULAR
    Inventors: Adys González Palomo, Adriana Carr Perez, Kalet León Monzón, Rancés Blanco Santana, María del Carmen Barroso Alvarez, Amparo Emilia Macías Abraham, José Enrique Montero Casimiro
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMORS EXPRESSING EGFR AND GM3 N-GLYCOLYL GANGLIOSIDE (NeuGcGM3)
    Publication number: 20140363494
    Abstract: The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N-glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.
    Type: Application
    Filed: December 4, 2012
    Publication date: December 11, 2014
    Inventors: Adys González Palomo, Adriana Carr Perez, Kalet León Monzón, Rancés Blanco Santana, María del Carmen Barroso Alvarez, Amparo Emilia Macías Abraham, José Enrique Montero Casimiro